DexCom (NASDAQ: DXCM)
DexCom Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
DexCom Company Info
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
News & Analysis
These 2 Growth Stocks Could Soar 33% and 45% According to Wall Street Analysts. Are They Smart Buys Now?
Expectations are high for companies making blood sugar monitors and business automation software.
2 No-Brainer Healthcare Stocks to Buy Right Now
Companies in the healthcare industry tend to generate returns in a wide range of market environments.
These 2 Growth Stocks Are Brilliant Buys for the New Year
Business is booming for these stocks, and investors might want to stop and take note.
Best 5G ETFs to Buy in 2023
Choosing an exchange-traded fund can provide diversification and possibly less volatility for your portfolio.
Is DexCom the Next Big Growth Stock?
It has significant growth drivers in play, but competitors are making inroads too.
Could DexCom Stock Help You Become a Millionaire?
DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future.
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
Investors could be making a mistake by selling off these stocks this year.
2 Growth Stocks That Could Help Set You Up for Life
These businesses have more beneath the surface than what their share prices might indicate.
Valuation
Earnings Transcripts
DexCom (DXCM) Q4 2023 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2023.
DexCom (DXCM) Q3 2023 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2023.
DexCom (DXCM) Q2 2023 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2023.
DexCom (DXCM) Q1 2023 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.